104 related articles for article (PubMed ID: 14561851)
21. Vascular VPO1 expression is related to the endothelial dysfunction in spontaneously hypertensive rats.
Yang L; Bai Y; Li N; Hu C; Peng J; Cheng G; Zhang G; Shi R
Biochem Biophys Res Commun; 2013 Oct; 439(4):511-6. PubMed ID: 24021280
[TBL] [Abstract][Full Text] [Related]
22. [The role of p38 MAPK in LPS induced ICAM-1 expression on endothelial cell].
Yan W; Jiang Y; Huang Q
Zhonghua Shao Shang Za Zhi; 2001 Feb; 17(1):32-5. PubMed ID: 11876908
[TBL] [Abstract][Full Text] [Related]
23. Chronic intermittent hypobaric hypoxia provides vascular protection in the aorta of the 2-kidney, 1-clip rat model of hypertension.
Fu C; Li N; Yuan Y; Wang R; Chen J; Yang J; Guo Z; Wang S; Zhang Y; Liu Y; Dong J
Can J Physiol Pharmacol; 2018 Aug; 96(8):807-814. PubMed ID: 29400080
[TBL] [Abstract][Full Text] [Related]
24. p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.
Toque HA; Romero MJ; Tostes RC; Shatanawi A; Chandra S; Carneiro ZN; Inscho EW; Webb RC; Caldwell RB; Caldwell RW
J Sex Med; 2010 Dec; 7(12):3857-67. PubMed ID: 20807329
[TBL] [Abstract][Full Text] [Related]
25. The inhibitory effect of docetaxel and p38 MAPK inhibitor on TZT-1027 (Soblidotin)-induced antivascular activity.
Watanabe J; Natsume T; Kobayashi M
Anticancer Res; 2007; 27(6B):3909-18. PubMed ID: 18225550
[TBL] [Abstract][Full Text] [Related]
26. Endothelial microparticles are increased in congenital heart diseases and contribute to endothelial dysfunction.
Lin ZB; Ci HB; Li Y; Cheng TP; Liu DH; Wang YS; Xu J; Yuan HX; Li HM; Chen J; Zhou L; Wang ZP; Zhang X; Ou ZJ; Ou JS
J Transl Med; 2017 Jan; 15(1):4. PubMed ID: 28049487
[TBL] [Abstract][Full Text] [Related]
27. p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts.
Agusti A; Cauli O; Rodrigo R; Llansola M; Hernández-Rabaza V; Felipo V
Gut; 2011 Nov; 60(11):1572-9. PubMed ID: 21636647
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunction.
Weerackody RP; Welsh DJ; Wadsworth RM; Peacock AJ
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1312-20. PubMed ID: 19201999
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II receptor type 1 autoantibodies promote endothelial microparticles formation through activating p38 MAPK pathway.
Yang S; Zhong Q; Qiu Z; Chen X; Chen F; Mustafa K; Ding D; Zhou Y; Lin J; Yan S; Deng Y; Wang M; Zhou Y; Liao Y; Zhou Z
J Hypertens; 2014 Apr; 32(4):762-70. PubMed ID: 24609215
[TBL] [Abstract][Full Text] [Related]
30. [Advanced glycation end products inhibit production of nitric oxide by human endothelial cells through activation of the p38 signal pathway].
Guo Z; Hou F; Zhang X; Liu Z; Wang L
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1328-31. PubMed ID: 12509937
[TBL] [Abstract][Full Text] [Related]
31. SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia.
Legos JJ; Erhardt JA; White RF; Lenhard SC; Chandra S; Parsons AA; Tuma RF; Barone FC
Brain Res; 2001 Feb; 892(1):70-7. PubMed ID: 11172750
[TBL] [Abstract][Full Text] [Related]
32. p38 MAPK regulates ischemia-reperfusion-induced recruitment of leukocytes in the colon.
Santén S; Mihaescu A; Laschke MW; Menger MD; Wang Y; Jeppsson B; Thorlacius H
Surgery; 2009 Mar; 145(3):303-12. PubMed ID: 19231583
[TBL] [Abstract][Full Text] [Related]
33. Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt.
Aceros H; Farah G; Cobos-Puc L; Stabile AM; Noiseux N; Mukaddam-Daher S
Br J Pharmacol; 2011 Oct; 164(3):946-57. PubMed ID: 21426316
[TBL] [Abstract][Full Text] [Related]
34. Evidence for activation of endothelium and monocytes in hypertensive rats.
Liu Y; Liu T; McCarron RM; Spatz M; Feuerstein G; Hallenbeck JM; Sirén AL
Am J Physiol; 1996 Jun; 270(6 Pt 2):H2125-31. PubMed ID: 8764265
[TBL] [Abstract][Full Text] [Related]
35. Effects of low dietary magnesium intake on development of hypertension in stroke-prone spontaneously hypertensive rats: role of reactive oxygen species.
Touyz RM; Pu Q; He G; Chen X; Yao G; Neves MF; Viel E
J Hypertens; 2002 Nov; 20(11):2221-32. PubMed ID: 12409961
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.
Barone FC; Irving EA; Ray AM; Lee JC; Kassis S; Kumar S; Badger AM; Legos JJ; Erhardt JA; Ohlstein EH; Hunter AJ; Harrison DC; Philpott K; Smith BR; Adams JL; Parsons AA
Med Res Rev; 2001 Mar; 21(2):129-45. PubMed ID: 11223862
[TBL] [Abstract][Full Text] [Related]
37. A cell permeant phosphopeptide mimetic of Niban inhibits p38 MAPK and restores endothelial function after injury.
Yim TW; Perling D; Polcz M; Komalavilas P; Brophy C; Cheung-Flynn J
FASEB J; 2020 Jul; 34(7):9180-9191. PubMed ID: 32396246
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologically activated migration of aortic endothelial cells is mediated through p38 SAPK.
Dénes L; Jednákovits A; Hargitai J; Pénzes Z; Balla A; Tálosi L; Krajcsi P; Csermely P
Br J Pharmacol; 2002 Jun; 136(4):597-603. PubMed ID: 12055138
[TBL] [Abstract][Full Text] [Related]
39. Phenoxypyrimidine inhibitors of p38alpha kinase: synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-(2-phenoxypyrimidin-4-yl) imidazoles.
Boehm JC; Bower MJ; Gallagher TF; Kassis S; Johnson SR; Adams JL
Bioorg Med Chem Lett; 2001 May; 11(9):1123-6. PubMed ID: 11354358
[TBL] [Abstract][Full Text] [Related]
40. Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity.
Adams JL; Boehm JC; Gallagher TF; Kassis S; Webb EF; Hall R; Sorenson M; Garigipati R; Griswold DE; Lee JC
Bioorg Med Chem Lett; 2001 Nov; 11(21):2867-70. PubMed ID: 11597418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
